Ivu Traffic Technologies AG/ DE0007448508 /
2022-02-08 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
22.5265USD | - | 39 Turnover: - |
-Bid Size: - | -Ask Size: - | 275.93 mill.USD | - | - |
GlobeNewswire
2:54 PM
SRCL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Stericycle to Waste...
Newsfile Corp
2:45 PM
Bassett Furniture Industries, Inc. to Present at Water Tower Research's Inaugural Consumer Products ...
GlobeNewswire
2:42 PM
EXL named a Leader in 2024 Gartner® Magic Quadrant™ for Finance and Accounting Business Process Outs...
GlobeNewswire
2:38 PM
Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tu...
GlobeNewswire
2:35 PM
IBN Announces Latest Episode of The Stock2Me Podcast featuring Brian J. Esposito, CEO of Diamond Lak...
GlobeNewswire
2:31 PM
German American Bancorp, Inc. announces the sale of the assets of German American Insurance, Inc. to...
Newsfile Corp
2:30 PM
GoGold Resources Inc. to Participate in THE Mining Investment Event of the North, Canada's Only Tier...
GlobeNewswire
2:30 PM
Safety Shot, World’s First Beverage to Reduce Blood Alcohol Content, Announces Launch of New 4-Ounce...
GlobeNewswire
2:30 PM
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives...
GlobeNewswire
2:30 PM
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placement...
GlobeNewswire
2:30 PM
Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform
GlobeNewswire
2:30 PM
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Cli...
GlobeNewswire
2:30 PM
LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer
GlobeNewswire
2:30 PM
Qlik Signs Strategic Collaboration Agreement with AWS to Accelerate Enterprise AI Adoption
GlobeNewswire
2:20 PM
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial